C71T
CANCELLED SECTION 71
14/08/2026
Voltar para busca
Dado oficial do USPTO
TULIP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
14/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
41, 42
Data de depósito
05/03/2018
Data de registro
28/01/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/08/2026
Última transação
14/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
NL
Examinador
LAM, HAI-LY HUYNH
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BYONDIS B.V.
Synthon Biopharmaceuticals B.V
Representantes
E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC
Classificação técnica
Classes Nice
Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 41
Publication of journalsnewsletters and scientific papers all featuring the results of clinical trials in the field of anticancer drugs; publication of journalsnewsletters and scientific papers all featuring results of clinical trials for pharmaceutical preparations
Classe 42
Performing clinical trials for others relating to pharmaceutical products in the field of anticancer drugs; providing medical and scientific research information on clinical trials in the field of anticancer medicines through an interactive website; providing medical and scientific research information in the field of pharmaceutical products and clinical trials in the field of anticancer drugs; conducting clinical trials for third parties in the field of anticancer drugs; conducting clinical trials for others; performing clinical trials for others in the field of pharmaceutical products; provision of information about the results of clinical trials for pharmaceutical products for scientific and medical research purposes; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing medical and scientific research information about clinical studies via an interactive website; all of the above services directed to pharmaceutical companies
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
28/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/11/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/11/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/06/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/05/2020
FIMP
FINAL DISPOSITION PROCESSED
08/05/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/04/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
28/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2019
PUBO
PUBLISHED FOR OPPOSITION
12/11/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/11/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/11/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/10/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/10/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/10/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
16/10/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/09/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
17/09/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/07/2019
GNFR
FINAL REFUSAL E-MAILED
10/07/2019
CNFR
FINAL REFUSAL WRITTEN
10/07/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
20/06/2019
ALIE
ASSIGNED TO LIE
13/06/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/11/2018
GNSL
LETTER OF SUSPENSION E-MAILED
15/11/2018
CNSL
SUSPENSION LETTER WRITTEN
15/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/10/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/10/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/10/2018
RFNT
REFUSAL PROCESSED BY IB
21/07/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/07/2018
RFRR
REFUSAL PROCESSED BY MPU
05/07/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/06/2018
CNRT
NON-FINAL ACTION WRITTEN
22/06/2018
DOCK
ASSIGNED TO EXAMINER
15/06/2018
MAFR
APPLICATION FILING RECEIPT MAILED
22/05/2018
MAFR
APPLICATION FILING RECEIPT MAILED
19/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/05/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/05/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TULIP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.